Outset Medical, Inc. (NASDAQ:OM) CFO Nabeel Ahmed Sells 34,288 Shares of Stock

Outset Medical, Inc. (NASDAQ:OM) CFO Nabeel Ahmed sold 34,288 shares of the company’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $0.80, for a total transaction of $27,430.40. Following the completion of the transaction, the chief financial officer now owns 258,869 shares in the company, valued at approximately $207,095.20. This trade represents a 11.70 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Nabeel Ahmed also recently made the following trade(s):

• On Monday, January 13th, Nabeel Ahmed sold 29,031 shares of Outset Medical stock. The stock was sold at an average price of $0.81, for a total value of $23,515.11.
• On Tuesday, January 7th, Nabeel Ahmed sold 1,835 shares of Outset Medical stock. The stock was sold at an average price of $1.29, for a total value of $2,367.15.
• On Friday, November 15th, Nabeel Ahmed sold 4,221 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total value of $3,376.80.

Outset Medical Stock Down 3.3 %

Shares of OM opened at $0.78 on Thursday. The company has a quick ratio of 5.04, a current ratio of 6.49 and a debt-to-equity ratio of 4.12. Outset Medical, Inc. has a 12 month low of $0.44 and a 12 month high of $5.22. The firm’s 50 day moving average is $1.01 and its 200-day moving average is $1.28.

Hedge Funds Weigh In On Outset Medical

A number of hedge funds have recently added to or reduced their stakes in the stock. Vanguard Personalized Indexing Management LLC acquired a new stake in Outset Medical during the second quarter worth about $49,000. Marshall Wace LLP lifted its holdings in shares of Outset Medical by 487.8% during the 2nd quarter. Marshall Wace LLP now owns 314,187 shares of the company’s stock worth $1,210,000 after acquiring an additional 260,740 shares during the period. Cubist Systematic Strategies LLC lifted its holdings in shares of Outset Medical by 228.3% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 200,939 shares of the company’s stock worth $774,000 after acquiring an additional 139,740 shares during the period. Squarepoint Ops LLC boosted its position in shares of Outset Medical by 74.1% during the 2nd quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock worth $309,000 after acquiring an additional 34,187 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in Outset Medical in the second quarter valued at approximately $259,000.

Analyst Ratings Changes

Separately, Royal Bank of Canada reiterated a “sector perform” rating and set a $3.00 price objective on shares of Outset Medical in a research report on Tuesday, January 7th.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.